Richard Kirkman

902 total citations
18 papers, 379 citations indexed

About

Richard Kirkman is a scholar working on Molecular Biology, Virology and Cancer Research. According to data from OpenAlex, Richard Kirkman has authored 18 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Virology and 4 papers in Cancer Research. Recurrent topics in Richard Kirkman's work include HIV Research and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (4 papers). Richard Kirkman is often cited by papers focused on HIV Research and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (4 papers). Richard Kirkman collaborates with scholars based in United States and Canada. Richard Kirkman's co-authors include Sunil Sudarshan, Casey D. Morrow, David A. Randolph, Suniti Bhaumik, Casey T. Weaver, Anirban Kundu, David T. Curiel, Matthew S. Mayo, Hyeyoung Nam and Mary E. Ballestas and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Richard Kirkman

17 papers receiving 374 citations

Peers

Richard Kirkman

GENET

PRM

IMMUN

ONCOL

Benjamin Müller Germany

Qi Deng China

Abdul Rouf Banday United States

Sylvia Metzner Germany

Deirdre Foley United States

Winnie Ngo United States

Christophe Kreis Canada

Marcelo Marcet‐Palacios Canada

Karl-Henning Kalland Norway

Florence Le Roy France

Benjamin Müller Germany

Richard Kirkman

158 ×0.7

45 ×0.7

GENET

28 ×0.5

PRM

39 ×0.7

IMMUN

41 ×0.9

ONCOL

Citations per year, relative to Richard Kirkman Richard Kirkman (= 1×) peers Benjamin Müller

Countries citing papers authored by Richard Kirkman

Since Specialization

Citations

This map shows the geographic impact of Richard Kirkman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Kirkman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Kirkman more than expected).

Fields of papers citing papers by Richard Kirkman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Kirkman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Kirkman. The network helps show where Richard Kirkman may publish in the future.

Co-authorship network of co-authors of Richard Kirkman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Kirkman. A scholar is included among the top collaborators of Richard Kirkman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Kirkman. Richard Kirkman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Nam, Hyeyoung, Anirban Kundu, Suman Karki, et al.. (2025). HDAC7 promotes renal cancer progression by reprogramming branched-chain amino acid metabolism. Science Advances. 11(23). eadt3552–eadt3552.

Nam, Hyeyoung, Anirban Kundu, Suman Karki, et al.. (2021). The TGF-β/HDAC7 axis suppresses TCA cycle metabolism in renal cancer. JCI Insight. 6(22). 23 indexed citations

Kundu, Anirban, Hyeyoung Nam, Sandeep B. Shelar, et al.. (2020). PRDM16 suppresses HIF-targeted gene expression in kidney cancer. The Journal of Experimental Medicine. 217(6). 29 indexed citations

Nam, Hyeyoung, Anirban Kundu, Garrett J. Brinkley, et al.. (2020). PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression. Matrix Biology. 89. 43–58. 20 indexed citations

Kundu, Anirban, Sandeep B. Shelar, Arindam Ghosh, et al.. (2020). 14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation. Journal of Biological Chemistry. 295(6). 1754–1766. 21 indexed citations

Brinkley, Garrett J., Hyeyoung Nam, Eun‐Hee Shim, et al.. (2020). Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney. Disease Models & Mechanisms. 13(11). 9 indexed citations

Kundu, Anirban, Sandeep B. Shelar, Hyeyoung Nam, et al.. (2018). Abstract 4483: Functional implications of PRDM16 loss in kidney cancer. Cancer Research. 78(13_Supplement). 4483–4483. 2 indexed citations

Livi, Carolina B., Phillip Buckhaults, Hyeyoung Nam, et al.. (2016). Abstract 53: Epigenetic silencing of krebs cycle metabolism in kidney cancer. Cancer Research. 76(14_Supplement). 53–53. 1 indexed citations

Ghosh, Arindam, Christopher B. Marshall, Tatjana Coric, et al.. (2015). Point mutations of the mTOR-RHEB pathway in renal cell carcinoma. Oncotarget. 6(20). 17895–17910. 59 indexed citations

10.

Bhaumik, Suniti, Thierry Giffon, Richard Kirkman, et al.. (2013). Retinoic Acid Hypersensitivity Promotes Peripheral Tolerance in Recent Thymic Emigrants. The Journal of Immunology. 190(6). 2603–2613. 14 indexed citations

11.

Bhaumik, Suniti, et al.. (2011). Developmental regulation of Th17‐cell capacity in human neonates. European Journal of Immunology. 42(2). 311–319. 56 indexed citations

12.

Palmer, Matthew T., Richard Kirkman, Barry Kosloff, Peter Eipers, & Casey D. Morrow. (2007). tRNA Isoacceptor Preference prior to Retrovirus Gag-Pol Junction Links Primer Selection and Viral Translation. Journal of Virology. 81(9). 4397–4404. 8 indexed citations

13.

Kosloff, Barry, et al.. (2005). Preferences for the selection of unique tRNA primers revealed from analysis of HIV-1 replication in peripheral blood mononuclear cells. Retrovirology. 2(1). 21–21. 10 indexed citations

14.

Kosloff, Barry, Nathan J. Kelly, Richard Kirkman, et al.. (2004). HIV Type 1 That Select tRNA ^His or tRNA ^Lys1,2 as Primers for Reverse Transcription Exhibit Different Infectivities in Peripheral Blood Mononuclear Cells. AIDS Research and Human Retroviruses. 20(4). 373–381. 9 indexed citations

15.

Han, Wenlong, Megan Wind‐Rotolo, Richard Kirkman, & Casey D. Morrow. (2004). Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site. Virology. 330(1). 221–232. 29 indexed citations

16.

Rogers, Buck E., D. W. Mccarthy, T Sharp, et al.. (2001). Evaluation of a ⁶⁴Cu‐labeled bombesin analogue for diagnosis of gastrin‐releasing peptide receptor positive tumors by micropet imaging. Journal of Labelled Compounds and Radiopharmaceuticals. 44(S1). 2 indexed citations

17.

Rogers, Buck E., Richard Kirkman, Christine Olsen, et al.. (1999). In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector.. PubMed. 5(2). 383–93. 76 indexed citations

18.

Bennett, L. Lee, William B. Parker, Paula W. Allan, et al.. (1993). Phosphorylation of the enantiomers of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinase.. Molecular Pharmacology. 44(6). 1258–1266. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact